financetom
Business
financetom
/
Business
/
Northern Oil & Gas Approves $150 Million Share Buyback Authorization, Plans 5% Increase to Quarterly Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northern Oil & Gas Approves $150 Million Share Buyback Authorization, Plans 5% Increase to Quarterly Dividend
Jul 29, 2024 5:29 AM

08:14 AM EDT, 07/29/2024 (MT Newswires) -- Northern Oil & Gas (NOG) said Monday that its board has approved a new $150 million share buyback authorization, replacing its previous authorization that had been significantly depleted.

The company said its management expects to submit a request to the board for a 5%, or $0.02, mid-year raise in the quarterly common dividend to $0.42 per share for Q3.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bank7 Insider Sold Shares Worth $312,068, According to a Recent SEC Filing
Bank7 Insider Sold Shares Worth $312,068, According to a Recent SEC Filing
Jul 23, 2026
09:06 AM EDT, 07/23/2026 (MT Newswires) -- Thomas L Travis, Director, President and Chief Executive Officer, on July 22, 2026, sold 6,500 shares in Bank7 ( BSVN ) for $312,068. Following the Form 4 filing with the SEC, Travis has control over a total of 265,601 common shares of the company, with 265,601 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1746129/000174612926000034/xslF345X05/form4.xml ...
Nuvectis Pharma Says Paroxysmal Nocturnal Hemoglobinuria Drug Approved by Chinese Regulator
Nuvectis Pharma Says Paroxysmal Nocturnal Hemoglobinuria Drug Approved by Chinese Regulator
Jul 23, 2026
09:07 AM EDT, 07/23/2026 (MT Newswires) -- Nuvectis Pharma ( NVCT ) said Thursday that ciprocopan, also known as NXP100, has received marketing approval from the National Medicinal Products Administration of China for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria who had previously been untreated with Complement inhibitors. China-based Haisco developed the drug and handles its development, regulatory approvals,...
Form 8.3
Form 8.3
Jul 23, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Teachers Insurance and Annuity Association of America/TIAA-CREF Investment Management, LLC/Teachers Advisors, LLC/ Nuveen Asset Management, LLC (b) Owner or controller of interests...
Troilus Mining Says Quebec Project Results Validate Mine Optimization Program
Troilus Mining Says Quebec Project Results Validate Mine Optimization Program
Jul 23, 2026
09:12 AM EDT, 07/23/2026 (MT Newswires) -- Troilus Mining ( CHXMF ) said Thursday that the third batch of results from the Troilus Project in north-central Quebec, help validate its mine plan optimization program. The Z87 optimization program, which will upgrade inferred material and target unsampled intervals from historic drilling within part of the main ore zone, returned 1.10 grams...
Copyright 2023-2026 - www.financetom.com All Rights Reserved